REPOSITORY ABOUT GUIDELINES CITING BLOG

10967/206 - QDB Compounds

QsarDB Repository

Oja, M.; Sild, S.; Maran, U. Logistic Classification Models for pH-Permeability Profile: Predicting Permeability Classes for the Biopharmaceutical Classification System. J. Chem. Inf. Model. 2019, 59, 2442-2455.

32 compounds | Property Class_FDA: BCS permeability class for FDA reference drugs i

ID Name Class_FDA Details
F01 Aciclovir L View
F02 Amiloride L View
F03 Antipyrine H View
F04 Atenolol L View
F05 Caffeine H View
F06 Carbamazepine H View
F07 Chlorphenamine L View
F08 Chlorthiazide L View
F09 Creatinine L View
F10 Disopyramide H View
F11 Enalapril L View
F12 Enalaprilat L View
F13 Famotidine L View
F14 Foscarnet L View
F15 Furosemide L View
F16 Hydrochlorothiazide L View
F17 Ketoprofen H View
F18 Lactulose L View
F19 Lisinopril L View
F20 Lucifer yellow L View
F21 Mannitol L View
F22 Metformin L View
F23 Metoprolol H View
F24 Minoxidil H View
F25 Nadolol L View
F26 Naproxen H View
F27 Phenytoin H View
F28 Propranolol H View
F29 Ranitidine L View
F30 Sulpiride L View
F31 Terbutaline L View
F32 Theophylline H View

Bibliography

  1. Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System, Guidance for Industry. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070246.pdf